Weight Loss
Got a few pounds to lose?
Obesity remains a pressing public health concern in the United States, with significant implications for individuals' health and well-being. According to the Centers for Disease Control and Prevention (CDC), obesity rates have been steadily rising over the past few decades, affecting approximately 42.4% of the adult population as of 2020. Obesity is commonly defined as having a body mass index (BMI) of 30 or higher, and its prevalence is associated with various factors, including sedentary lifestyles, poor dietary habits, socioeconomic status, and genetic predisposition.
The health consequences of obesity are profound and multifaceted. Excess weight is linked to an increased risk of developing a wide range of chronic conditions, including type 2 diabetes, cardiovascular disease, hypertension, stroke, certain cancers, osteoarthritis, and sleep apnea. Moreover, obesity can exacerbate existing health problems, reduce life expectancy, and diminish quality of life. The economic burden of obesity is also substantial, with healthcare costs related to obesity-related conditions estimated to be billions of dollars annually.
Addressing obesity requires a comprehensive approach that encompasses lifestyle modifications, dietary changes, physical activity, behavioral therapy, and, in some cases, medical intervention. Medical weight loss programs offer a structured and supervised approach to weight management, typically under the guidance of healthcare professional. There are many avenues for medical aids in assisting with weight loss but important to know that these are tools to be utilized and not solutions to long term success.
These services are offered via Telehealth to anyone in MD, VA, PA, WV, FL, NV and DE, as well as our physical location in Hagerstown, MD.
What are my options?
While not an exhaustive list, below lists some common options to consider. In addition to considering these options, it should be advised that having a hormone consultation first would likely yield more optimal results than considering one of these options by themselves, this even includes the thyroid. Diet and exercise are also pillars to successful outcomes.
​
​GLP1's: GLP-1 receptor agonists, along with GIP and glucagon receptor agonists, offer significant benefits in managing metabolic disorders. GLP-1 agonists help regulate blood sugar levels by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, which also aids in weight loss. GIP receptor agonists complement these effects by improving insulin sensitivity and promoting fat metabolism. Meanwhile, glucagon receptor agonists contribute to increased energy expenditure and may support weight management and metabolic health. Together, these therapies provide a multifaceted approach to treating conditions like type 2 diabetes and obesity.
MOTS-C: Mitochondrial-derived peptide (Mots-c) is a novel intervention for weight loss that targets cellular metabolism and energy balance. Mots-c regulates mitochondrial function, promoting increased energy expenditure and fat oxidation while improving insulin sensitivity. By enhancing cellular metabolism, Mots-c can help individuals achieve sustainable weight loss and metabolic health improvements. Its mechanism of action underscores the importance of mitochondrial function in regulating body weight and offers a promising avenue for therapeutic interventions.
Growth hormone releasing peptides: Growth hormone releasing peptides (GHRPs) stimulate the secretion of growth hormone from the pituitary gland, which plays a crucial role in regulating metabolism, fat metabolism, and muscle growth. GHRPs have been investigated for their potential to promote weight loss by increasing energy expenditure, reducing fat mass, and preserving lean muscle mass. These peptides offer a targeted approach to addressing metabolic imbalances and may be beneficial for individuals with growth hormone deficiencies or obesity-related complications.
Tesofenisine: Tesofenisine is a pharmacological agent with dual activity on noradrenaline and serotonin reuptake, making it a promising candidate for weight loss interventions. By modulating neurotransmitter activity, tesofenisine regulates appetite, reduces food intake, and enhances thermogenesis, leading to significant weight loss. Its unique mechanism of action distinguishes it from traditional weight loss medications and offers potential benefits for individuals struggling with obesity and metabolic syndrome.
AOD-9604: AOD-9604 is a peptide derived from growth hormone that targets fat metabolism by stimulating lipolysis, the breakdown of fat cells. It works by enhancing the breakdown of stored fats while inhibiting the accumulation of new fat cells, leading to reductions in body fat mass. AOD-9604's ability to promote fat loss without affecting lean muscle mass makes it an attractive option for individuals seeking effective weight management strategies with minimal side effects.
Topical aminophylline/glycyrrhetinic acid: Topical aminophylline combined with glycyrrhetinic acid offers a localized approach to weight loss by targeting subcutaneous fat tissue. Aminophylline, a bronchodilator, stimulates lipolysis, while glycyrrhetinic acid inhibits the activity of an enzyme involved in fat cell formation. This combination enhances fat burning and reduces the appearance of cellulite, making it a popular choice for topical fat reduction treatments. Its localized action minimizes systemic side effects, offering a safe and effective option for enhancing body contouring and reducing stubborn fat deposits. This is a great option for targeted areas such as belly fat.
There is never a better time than now.
Get in touch and lets get the ball rolling so you can achieve your true potential.
Address
18117 Maugans Ave Ste 201
Hagerstown, MD 21740
Phone
240-563-9247
